Narrow search
Showing 1 - 10 of 1,419
Cover Image
Innovation diffusion under budget constraints : Microeconometric evidence on heart attack in France
Dormont, Brigitte; Milcent, Carine - Université Paris-Dauphine (Paris IX) - 2005
hospitals, we use microsimulation techniques to highlight various effects on the shifts in the overall distribution of the costs … and length of stays : (i) the effect of the adoption of new techniques by hospitals (between hospital diffusion) ; (ii …) the effect of the diffusion of technological progress within hospitals ; (iii) the effect of changes in patients …
Persistent link: https://www.econbiz.de/10010708126
Cover Image
Innovation diffusion under budget constraints : Microeconometric evidence on heart attack in France.
Dormont, Brigitte; Milcent, Carine - Université Paris-Dauphine - 2005
hospitals, we use microsimulation techniques to highlight various effects on the shifts in the overall distribution of the costs … and length of stays : (i) the effect of the adoption of new techniques by hospitals (between hospital diffusion) ; (ii …) the effect of the diffusion of technological progress within hospitals ; (iii) the effect of changes in patients …
Persistent link: https://www.econbiz.de/10008790062
Cover Image
Spillover Effects of the Opioid Epidemic on Labor and Innovation
Louca, Christodoulos; Michaely, Roni; Petmezas, Dimitris - 2022
Using two independent exogenous shocks, we investigate whether the opioid epidemic affects labor and innovation even when personal addiction is not the main driver. Exploiting a setting of corporate innovation where production is mostly generated by white-collar individuals - unlikely addicts -...
Persistent link: https://www.econbiz.de/10014235638
Cover Image
Innovation Institutions and the Opioid Crisis
Hemel, Daniel Jacob - 2020
The United States has recently — and belatedly — come to recognize opioid addiction as a public health crisis. What has gone mostly unrecognized is the degree to which this crisis is intertwined with U.S. intellectual property law and related elements of U.S. innovation policy. Innovation...
Persistent link: https://www.econbiz.de/10012842004
Cover Image
Innovation Institutions and COVID-19, Part II
Ouellette, Lisa Larrimore; Price II, W. Nicholson; … - 2022
The COVID-19 crisis has starkly illustrated both the strengths and limitations of U.S. biomedical innovation institutions as deployed to fight a pandemic. These innovation institutions include not just intellectual property law, but also other legal systems that structure incentives for...
Persistent link: https://www.econbiz.de/10014081533
Cover Image
Externalities from Medical Innovation : Evidence from Organ Transplantation
Callison, Kevin; Darden, Michael; Teltser, Keith F. - National Bureau of Economic Research - 2023
We evaluate the introduction of direct-acting antiviral (DAA) therapy for Hepatitis C (HCV) on liver transplant allocation in the United States. We develop a model of listing and organ acceptance behavior for patients with both HCV-positive and HCV-negative end-stage liver disease. In the model,...
Persistent link: https://www.econbiz.de/10014372430
Cover Image
Bad Translation or Double Standards? Productivity and Accountability Across the Private, Public and Voluntary Sectors
Stein, Janice - Center for the Study of Living Standards (CSLS); The …
In this chapter by Janice Stein warns about the dangers of adopting a narrow conception of productivity and efficiency. Building on her analysis in The Cult of Efficiency, she argues that the language of efficiency, understood narrowly as cost-effectiveness, confronts distinctive problems when...
Persistent link: https://www.econbiz.de/10005481814
Cover Image
The innovative, demand-based organizational design for efficient oncological care in Poland : a Voronoi diagram analysis
Karpa, Waldemar; Nowakowski, Jakub - 2015
In this paper, we apply a Voronoi diagram to map the existing design of oncological care in Poland. First, we correlate the actual organization of care with epidemiological data on cancer survival rate and morbidity. On this basis, we build a proxy for localized demand for oncological care. As a...
Persistent link: https://www.econbiz.de/10011548767
Cover Image
Regulatory Incentives for Innovation : The FDA's Breakthrough Therapy Designation
Chandra, Amitabh; Kao, Jennifer L.; Miller, Kathleen; … - 2022
Regulators of new products confront a tradeoff between speeding a new product to market and collecting additional product quality information. The FDA’s Breakthrough Therapy Designation (BTD) provides an opportunity to understand if a regulator can use new policy to innovate around this...
Persistent link: https://www.econbiz.de/10014240778
Cover Image
Criminal, Legal, and Ethical Kidney Donation and Transplantation : A Conceptual Framework to Enable Innovation
Roth, Alvin E.; Marino, Ignazio R.; Krawiec, Kimberly D.; … - 2022
This article distinguishes criminal, legal, and ethical transplantation as three distinct concepts, with the goal of building a conceptual framework to enable innovation. We strongly believe that international efforts should concentrate on increasing the availability of ethical high-quality...
Persistent link: https://www.econbiz.de/10014081649